Resources Contact Us Home
Immunoreactive peptides from Epstein-Barr virus

Image Number 3 for United States Patent #7988972.

The Epstein-Barr virus (EBV) specific polypeptides ETFTETWNRFITHTE (SEQ. ID NO: 1), GMLEASEGLDGWIHQ (SEQ. ID NO:2), HQQGGWSTLIEDNIP (SEQ. ID NO:3), and KQKHPKKVKQAFNPL (SEQ. ID NO:4) are among those disclosed. Also disclosed are the use of these polypeptides for the production of polypeptide-specific antibodies and the diagnosis and treatment of EBV-associated disease.

  Recently Added Patents
Control unit including a computing device and a peripheral module which are interconnected via a serial multiwire bus
Critical word forwarding with adaptive prediction
Measurement of an analyte on the skin using a hue angle
Visual model importation
Digital broadcasting system and method of processing data
Solid-state image capture device and image capture apparatus
System and method for combining different tablets into a pouch
  Randomly Featured Patents
Rack and pinion pneumatic actuator with counter-pressure control and damping device
Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopes
Prostaglandin E1 derivatives as pharmaceutically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration
Electric heat exchanger
Methods for audio capture and communication during television broadcasts
Open tip for hearing aid
Scent-Emitting Systems
System and method for automated placement in custom VLSI circuit design with schematic-driven placement
Stop and waste valve construction
Stackable chair